Desmoid Fibromatosis — Trials

Desmoid Fibromatosis — Trials · CancerIndex

Clinical trials

Registered studies

52 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03785964	Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)(DeFi)	completed	Phase 3	142	SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, GermanyINDUSTRY	7	Aug 20, 2026	clinicaltrials
NCT02066181	Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis	completed	Phase 3	87	National Cancer Institute (NCI)NIH	2